Why is Pharmaids Pharma falling/rising?

As of 01-Oct, Pharmaids Pharmaceuticals Ltd is experiencing a slight decline in its stock price, currently at 59.40, down by 0.06 or 0.1%. The stock has underperformed its sector by 1.46% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 2.59% in that period. Although the stock has shown strong long-term performance with a 45.48% return over the past year and impressive gains over three and five years, it is facing challenges such as operating losses and a negative EBITDA, which contribute to its weak long-term fundamental strength. Additionally, the stock's delivery volume has decreased significantly, indicating falling investor participation.
In the broader market context, Pharmaids Pharmaceuticals has outperformed the Sensex over the long term, particularly in the last three years, where it achieved a return of 339.67% compared to the benchmark's 41.02%. However, in the short term, the stock's performance has been less favorable, with a 1.05% gain over the past week while the Sensex declined by 0.90%. This disparity highlights the stock's recent struggles despite its historical performance, as it grapples with poor operating profit growth and a high debt-to-EBITDA ratio, which may deter investors in the current market environment.